Latest Articles

Publication Date
All News Scientific
Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026 - Business Wire

Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026 Business Wire

Published: Sept. 8, 2026, 11:30 a.m.
Read Full Article
Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026 - businesswire.com

Faeth Therapeutics to Host Virtual KOL Event on Multi-Nodal Inhibition for the Treatment of Endometrial Cancer on October 6, 2026 businesswire.com

Published: Sept. 8, 2026, 11:30 a.m.
Read Full Article
Advanced Endometrial Cancer Clinical Trial Pipeline Analysis: 25+ Key Companies Shaping the Future of Advanced Endometrial Cancer Therapeutics Space | DelveInsight - Business Upturn

Advanced Endometrial Cancer Clinical Trial Pipeline Analysis: 25+ Key Companies Shaping the Future of Advanced Endometrial Cancer Therapeutics Space | DelveInsight Business Upturn

Published: Sept. 3, 2026, 7:35 p.m.
Read Full Article
Advanced Endometrial Cancer Clinical Trial Pipeline Analysis: 25+ Key Companies Shaping the Future of Advanced Endometrial Cancer Therapeutics Space | DelveInsight - The Manila Times

Advanced Endometrial Cancer Clinical Trial Pipeline Analysis: 25+ Key Companies Shaping the Future of Advanced Endometrial Cancer Therapeutics Space | DelveInsight The Manila Times

Published: Sept. 3, 2026, 5:03 p.m.
Read Full Article
EndoCyclic Therapeutics Nominated for 2026 Prix Galien USA Award - StreetInsider

EndoCyclic Therapeutics Nominated for 2026 Prix Galien USA Award StreetInsider

Published: Aug. 20, 2026, 6:39 a.m.
Read Full Article
Exclusive BAC Article: Faeth Therapeutics; Year-End 2026 PIKTOR Endometrial Cancer Data, Breast Cancer Interim Results 2027, Solid Tumor Expansions, And Catalysts (NASDAQ:FTH) - Seeking Alpha

Exclusive BAC Article: Faeth Therapeutics; Year-End 2026 PIKTOR Endometrial Cancer Data, Breast Cancer Interim Results 2027, Solid Tumor Expansions, And Catalysts (NASDAQ:FTH) Seeking Alpha

Published: Aug. 17, 2026, 7:11 p.m.
Read Full Article
Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer - BioSpace

Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer BioSpace

Published: Aug. 17, 2026, 1:47 p.m.
Read Full Article
Faeth Therapeutics (FTH) Gains FDA Fast Track for Endometrial Ca - GuruFocus

Faeth Therapeutics (FTH) Gains FDA Fast Track for Endometrial Ca GuruFocus

Published: Aug. 17, 2026, 12:03 p.m.
Read Full Article
Faeth Therapeutics (FTH) Gains FDA Fast Track for Endometrial Cancer Combo Therapy - GuruFocus

Faeth Therapeutics (FTH) Gains FDA Fast Track for Endometrial Cancer Combo Therapy GuruFocus

Published: Aug. 17, 2026, 12:03 p.m.
Read Full Article
Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer - Business Wire

Faeth Therapeutics Announces FDA Grant of Fast Track Designation for PIKTOR Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer Business Wire

Published: Aug. 17, 2026, 11:30 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!